These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9103394)

  • 1. High-dose-rate brachytherapy in the management of high-grade intraepithelial neoplasia of the vagina.
    MacLeod C; Fowler A; Dalrymple C; Atkinson K; Elliott P; Carter J
    Gynecol Oncol; 1997 Apr; 65(1):74-7. PubMed ID: 9103394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 20-year retrospective review of medium dose rate intracavitary brachytherapy in VAIN3.
    Graham K; Wright K; Cadwallader B; Reed NS; Symonds RP
    Gynecol Oncol; 2007 Jul; 106(1):105-11. PubMed ID: 17481703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose-rate definitive brachytherapy for high-grade vaginal intraepithelial neoplasia.
    Blanchard P; Monnier L; Dumas I; Morice P; Pautier P; Duvillard P; Azoury F; Mazeron R; Haie-Meder C
    Oncologist; 2011; 16(2):182-8. PubMed ID: 21262875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features and risk of recurrence among patients with vaginal intraepithelial neoplasia.
    Dodge JA; Eltabbakh GH; Mount SL; Walker RP; Morgan A
    Gynecol Oncol; 2001 Nov; 83(2):363-9. PubMed ID: 11606098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
    Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
    Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose-rate interstitial brachytherapy for gynecologic malignancies.
    Beriwal S; Bhatnagar A; Heron DE; Selvaraj R; Mogus R; Kim H; Gerszten K; Kelley J; Edwards RP
    Brachytherapy; 2006; 5(4):218-22. PubMed ID: 17118313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perineal template interstitial brachytherapy salvage for recurrent endometrial adenocarcinoma metastatic to the vagina.
    Nag S; Martínez-Monge R; Copeland LJ; Vacarello L; Lewandowski GS
    Gynecol Oncol; 1997 Jul; 66(1):16-9. PubMed ID: 9234914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes after diagnosis of vaginal intraepithelial neoplasia.
    Massad LS
    J Low Genit Tract Dis; 2008 Jan; 12(1):16-9. PubMed ID: 18162807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy.
    Wazer DE; Kaufman S; Cuttino L; DiPetrillo T; Arthur DW
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):489-95. PubMed ID: 16246495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical analysis of 20 patients with vaginal intraepithelial neoplasia].
    Li SM; Zhang WH; Bai P; Li HJ; Zhang R; Wu LY
    Zhonghua Fu Chan Ke Za Zhi; 2009 Apr; 44(4):277-80. PubMed ID: 19570466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiotherapy alone for invasive vaginal cancer: outcome with intracavitary high dose rate brachytherapy versus conventional low dose rate brachytherapy.
    Kucera H; Mock U; Knocke TH; Kucera E; Pötter R
    Acta Obstet Gynecol Scand; 2001 Apr; 80(4):355-60. PubMed ID: 11264612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of low and high dose rate brachytherapy in the treatment of uterine cervix cancer. Retrospective analysis of two sequential series.
    Ferrigno R; Nishimoto IN; Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Salvajoli JV
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1108-16. PubMed ID: 15990016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose-rate brachytherapy in uterine cervical carcinoma.
    Patel FD; Rai B; Mallick I; Sharma SC
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):125-30. PubMed ID: 15850912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for recurrence of vaginal intraepithelial neoplasia in the vaginal vault after laser vaporization.
    Kim HS; Park NH; Park IA; Park JH; Chung HH; Kim JW; Song YS; Kang SB
    Lasers Surg Med; 2009 Mar; 41(3):196-202. PubMed ID: 19291750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radical radiotherapy with high-dose-rate brachytherapy for uterine cervix cancer long-term results.
    Khor TH; Tuan JK; Hee SW; Tham IW
    Australas Radiol; 2007 Dec; 51(6):570-7. PubMed ID: 17958695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brachytherapy for vaginal intraepithelial neoplasia.
    Zolciak-Siwinska A; Gruszczynska E; Jonska-Gmyrek J; Kulik A; Michalski W
    Eur J Obstet Gynecol Reprod Biol; 2015 Nov; 194():73-7. PubMed ID: 26334358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term cosmesis after lumpectomy and brachytherapy in the management of carcinoma of the previously irradiated breast.
    Trombetta M; Julian TB; Werts DE; McWilliams W; Kim Y; Miften M; Parda D
    Am J Clin Oncol; 2009 Jun; 32(3):314-8. PubMed ID: 19451803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anal canal carcinoma: early-stage tumors < or =10 mm (T1 or Tis): therapeutic options and original pattern of local failure after radiotherapy.
    Ortholan C; Ramaioli A; Peiffert D; Lusinchi A; Romestaing P; Chauveinc L; Touboul E; Peignaux K; Bruna A; de La Roche G; Lagrange JL; Alzieu C; Gerard JP
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):479-85. PubMed ID: 15890590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer.
    Alektiar KM; Venkatraman E; Chi DS; Barakat RR
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):111-7. PubMed ID: 15850910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.